Evidence map›Paper›PMID 33623001›Full record

ArticleNature communications2021

Facilitative lysosomal transport of bile acids alleviates ER stress in mouse hematopoietic precursors.

Avinash K Persaud, Sreenath Nair, Md Fazlur Rahman, Radhika Raj, Brenna Weadick, Debasis Nayak, Craig McElroy, Muruganandan Shanmugam, Sue Knoblaugh, Xiaolin Cheng and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Autophagy · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Inborn Errors of Nucleoside Transporter (NT)-Encoding Genes (International journal of molecular sciences · 2022
    Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Avinash K PersaudDivision of Pharmaceutics & Pharmacology, College of Pharmacy, Ohio State University, Columbus, OH, 43210, USA.
Sreenath NairDivision of Pharmaceutics & Pharmacology, College of Pharmacy, Ohio State University, Columbus, OH, 43210, USA.
Md Fazlur RahmanDivision of Pharmaceutics & Pharmacology, College of Pharmacy, Ohio State University, Columbus, OH, 43210, USA.
Radhika RajDivision of Pharmaceutics & Pharmacology, College of Pharmacy, Ohio State University, Columbus, OH, 43210, USA.
Brenna WeadickDivision of Pharmaceutics & Pharmacology, College of Pharmacy, Ohio State University, Columbus, OH, 43210, USA.
Debasis NayakDivision of Pharmaceutics & Pharmacology, College of Pharmacy, Ohio State University, Columbus, OH, 43210, USA.
Craig McElroyDivision of Pharmaceutics & Pharmacology, College of Pharmacy, Ohio State University, Columbus, OH, 43210, USA.ORCID 0000-0001-5950-0120
Muruganandan ShanmugamDivision of Pharmaceutics & Pharmacology, College of Pharmacy, Ohio State University, Columbus, OH, 43210, USA.
Sue KnoblaughDepatment of Veterinary Biosciences, College of Veterinary Medicine, Ohio State University, Columbus, OH, 43210, USA.
Xiaolin ChengDivision of Medicinal Chemistry & Pharmacognosy, College of Pharmacy, Ohio State University, Columbus, OH, 43210, USA.
Rajgopal GovindarajanDivision of Pharmaceutics & Pharmacology, College of Pharmacy, Ohio State University, Columbus, OH, 43210, USA. govindarajan.21@osu.edu.ORCID 0000-0002-2958-5773
The Ohio State University · USTranslational Therapeutics (United States) · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Jennifer A. Woyach · 1985 to 2026
$132.3M
Epigenetic priming in pancreatic cancer chemotherapyR01CA188464 · NCI · UNIVERSITY OF GEORGIA · PI GOVINDARAJAN, RAJGOPAL · 2014 to 2018
$1.6M
Elucidating mitochondrial pathomechanisms of ENT3 disorders in ENT3 KO miceR03AR063326 · NIAMS · UNIVERSITY OF GEORGIA · PI GOVINDARAJAN, RAJGOPAL · 2013 to 2015
$225k
NCI NIH HHS P30 CA016058NCI NIH HHS R01 CA188464NIAMS NIH HHS R03 AR063326
6 · The paper itself

Abstract

Mutations in human equilibrative nucleoside transporter 3 (ENT3) encoded by SLC29A3 results in anemia and erythroid hypoplasia, suggesting that ENT3 may regulate erythropoiesis. Here, we demonstrate that lysosomal ENT3 transport of taurine-conjugated bile acids (TBA) facilitates TBA chemical chaperone function and alleviates endoplasmic reticulum (ER) stress in expanding mouse hematopoietic stem and progenitor cells (HSPCs). Slc29a3

Indexed as

Endoplasmic Reticulum StressAnimalsApoptosisBile Acids and SaltsBiological TransportBone Marrow CellsCell DifferentiationCell SurvivalEndoplasmic ReticulumErythroid CellsHematopoietic Stem CellsHematopoietic Stem Cell TransplantationHydrogen-Ion ConcentrationLysosomesMetabolomicsMiceBile Acids and SaltsNucleoside Transport ProteinsSlc29a3 protein, mouseTaurineTaurochenodeoxycholic Acidursodoxicoltaurine

Identifiers

PMID33623001
PMCPMC7902824
OpenAlexW3133438979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.